Literature DB >> 14682611

Withania somnifera (Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications.

Sanjeev K Gupta1, Anita Dua, Bhupinder P S Vohra.   

Abstract

Withania somnifera is classified in Ayurveda, the ancient Indian system of medicine, as a rasayana, a group of plant-derived drugs which promote physical and mental health, augment resistance of the body against disease and diverse adverse environmental factors, revitalize the body in debilitated conditions and increase longevity. We investigated the effects of Withania somnifera on copper-induced lipid peroxidation and antioxidant enzymes in aging spinal cord of Wistar rats. The activity of glutathione peroxidase (GPx) decreased significantly in the spinal cord from adult to aged mice. Treatment with Withania somnifera successfully attenuated GPx activity and inhibited lipid peroxidation in a dose dependent manner. Withania somnifera inhibited both the lipid peroxidation and protein oxidative modification induced by copper. These effects were similar to those of superoxide dismutase and mannitol. The results indicate the therapeutic potential of Withania somnifera in aging and copper-induced pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682611     DOI: 10.1515/dmdi.2003.19.3.211

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  8 in total

1.  Functional characterization and differential expression studies of squalene synthase from Withania somnifera.

Authors:  Neha Gupta; Poonam Sharma; R J Santosh Kumar; Rishi K Vishwakarma; B M Khan
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

2.  Neuroprotective effects of Withania somnifera dunal.: A possible mechanism.

Authors:  Maheep Bhatnagar; Durgesh Sharma; Mahendra Salvi
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

Review 3.  Plant-based Rasayana drugs from Ayurveda.

Authors:  Subramani Paranthaman Balasubramani; Padma Venkatasubramanian; Subrahmanya Kumar Kukkupuni; Bhushan Patwardhan
Journal:  Chin J Integr Med       Date:  2011-03-09       Impact factor: 1.978

4.  Phytoremedial effect of Withania somnifera against arsenic-induced testicular toxicity in Charles Foster rats.

Authors:  Arun Kumar; Ranjit Kumar; Mohammad Samuir Rahman; Mohammad Asif Iqubal; Gautam Anand; Pintoo Kumar Niraj; Mohammad Ali
Journal:  Avicenna J Phytomed       Date:  2015 Jul-Aug

Review 5.  Plants and phytochemicals for Huntington's disease.

Authors:  Sunayna Choudhary; Puneet Kumar; Jai Malik
Journal:  Pharmacogn Rev       Date:  2013-07

6.  Phytochemical Identification, Acute, and Sub-Acute Oral Toxicity Studies of the Foliar Extract of Withania frutescens.

Authors:  Abdelfattah El Moussaoui; Mohammed Bourhia; Fatima Zahra Jawhari; Hamza Mechchate; Meryem Slighoua; Ahmed Bari; Riaz Ullah; Hafiz Majid Mahmood; Syed Saeed Ali; Samir Ibenmoussa; Dalila Bousta; Amina Bari
Journal:  Molecules       Date:  2020-10-02       Impact factor: 4.411

7.  Withania frutescens. L Extract: Phytochemical Characterization and Acute and Repeated Dose 28-Day Oral Toxicity Studies in Mice.

Authors:  Abdelfattah El Moussaoui; Mohammed Bourhia; Fatima Zahra Jawhari; Imane Es-Safi; Syed Saeed Ali; Ahmed Bari; Hafiz Majid Mahmood; Dalila Bousta; Amina Bari
Journal:  Biomed Res Int       Date:  2020-09-26       Impact factor: 3.411

Review 8.  Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.

Authors:  Sukriti Vishwas; Monica Gulati; Bhupinder Kapoor; Saurabh Gupta; Sachin Kumar Singh; Ankit Awasthi; Arzoo Khan; Aditya Goyal; Anil Bansal; Suman Baishnab; Thakur Gurjeet Singh; Sandeep Arora; Omji Porwal; Ankit Kumar; Vijay Kumar
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.